Member access

4-Traders Homepage  >  Shares  >  Swiss Exchange  >  Novartis AG    NOVN   CH0012005267

NOVARTIS AG (NOVN)

174
Delayed Quote. Delayed BATS EUROPE - 10/31 05:30:00 pm
89.2250 CHF   -0.08%
3d ago NOVARTIS : Psoriasis is so much more than a skin disease and has effects on..
3d agoDJNorway's Oil Fund Posts Flat Returns in 3Q
3d agoDJNorway's Oil Fund Posts Flat Returns in 3Q--Update
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Swiss Exchange
10/27/2014 10/28/2014 10/29/2014 10/30/2014 10/31/2014 Date
85.7(c) 87.25(c) 86.9(c) 87.7(c) 89.3(c) Last
3 622 386 5 913 185 4 738 746 5 071 218 9 422 653 Volume
-0.06% +1.81% -0.40% +0.92% +1.82% Change
More quotes
Company
Novartis AG develops, manufactures, and markets healthcare products.It operates through the following segments: Pharmaceuticals, Alcon, Sandoz, Vaccines and Diagnostics, and Consumer Health.The Pharmaceuticals segment provides patent-protected prescription medicines.The Alcon segment offers... 
Sector
Pharmaceuticals
Calendar
11/11 | 01:30pmPresentation
Surperformance© rating of Novartis AG
Trading Rating : Investor Rating :
More about the company
Chart NOVARTIS AG
Duration : Period :
Novartis AG Technical Analysis Chart | NOVN | CH0012005267 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 58 748 M
EBIT 2014 13 927 M
Net income 2014 10 482 M
Debt 2014 5 790 M
Yield 2014 2,89%
Sales 2015 57 464 M
EBIT 2015 14 463 M
Net income 2015 11 335 M
Debt 2015 8 197 M
Yield 2015 3,09%
PER 2014 22,03
PER 2015 20,19
EV / Sales 2014 4,40x
EV / Sales 2015 4,54x
Capitalization 252 812 M
More Financials
Latest news on NOVARTIS AG
1d ago NOVARTIS : Cipla in patent fight (drug war)
2d ago Ranbaxy sees first profit in six qtrs on Diovan sales
2d ago RANBAXY TURNS AROUND, POSTS Rs478-CRORE PROFIT IN Q2
3d ago NOVARTIS : European shares rise
3d ago NOVARTIS : Psoriasis is so much more than a skin disease and has effects on peop..
3d agoDJNorway's Oil Fund Posts Flat Returns in 3Q
3d agoDJNorway's Oil Fund Posts Flat Returns in 3Q--Update
4d ago NOVARTIS : New Report Available: Cough, Cold and Allergy (Hay Fever) Remedies in..
4d ago Ranbaxy surges after profit, Sun Pharma also gains
4d agoDJEuropean Stocks Rebound But Investors Remain Cautious -- 3rd Update
4d agoDJEUROPE MARKETS : European Stocks Rebound; Stoxx 600 Up 1%
4d agoDJEuropean Stocks Rise But Investors Remain Cautious --2nd Update
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF